77  Vaccine Trials Quick Reference

Endpoint validity in vaccine trials is frequently dependent on precise timing of vaccination and follow-up visits.

NoteCRA Considerations

CRAs should pay particular attention to visit window compliance, vaccination timing, and specimen collection timing. Out-of-window visits may directly affect endpoint validity and should be documented and escalated appropriately.